DFX Intelligence

Data Factory

Sail Biomedicines

A Flagship Pioneering Company Pioneering In Vivo CAR-T at scale By instructing immune cells to act directly inside the body,..

This is the graph view. The full profile, with its team, deals and sources, is on Venture Capital.Open the full profile →

Search this name across graphsid dfx:vc:28eaefa0-1811-4275-9d4c-130a3679473d

Data as of Sep 17, 2026 (this record's last observation) from Sworn filings; Announcements; Limited partners. Page built Sep 20, 2026, 11:13 AM UTC and rebuilt at most every 15 minutes.

Relationships: 3
Dated events: 1
On other graphs: 1
Observed: Sep 13, 2026 to Sep 17, 2026
7 observations

Across DFX

same identity by shared identifier, citation, or a bridge measured by hand

Private Equityidentity

Sail Biomedicines

Portfolio company · cited

Facts

fact = as filed or announced; derived = computed by DFX; estimate = a band, never a point

Rounds: 0
Investors: 3
People: 0
Website: sail.bio

Investors

Investor	Class	Fund	Partner	Role	Attribution
Stage 1 Managers LLC	Seed fund manager	n/a	n/a	unknown	Unknown
Sanofi	Candidate VC	n/a	n/a	unknown	Unknown
Omega Fund Management, LLC	Institutional VC	n/a	n/a	unknown	Unknown

Relationships

Invested in (3)

← Stage 1 Managers LLCFirmPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
← SanofiFirmPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
← Omega Fund Management, LLCFirmPortfolio listing
Sep 13, 2026 to presentfactThe subject's own site

Dated events

1 bookkeeping events (roster, classification and holdings changes) folded below

Show 1 bookkeeping events

First seen by DFX
Sep 16, 2026
date not stated
Sail Biomedicines no longer listed on Omega Fund Management, LLC's portfolio page

Provenance

Graph: Venture Capital
Canonical id: dfx:vc:28eaefa0-1811-4275-9d4c-130a3679473d
First observed: Sep 13, 2026
Last observed: Sep 17, 2026 3 days ago
Resolution: Identity across graphs by shared identifier (CRD, CIK, EIN, ADV fund id, individual CRD) or citation; a name match is shown as a candidate and never merged.

Sail Biomedicines

A Flagship Pioneering Company Pioneering In Vivo CAR-T at scale By instructing immune cells to act directly inside the body,..

This is the graph view. The full profile, with its team, deals and sources, is on Venture Capital.Open the full profile →

Search this name across graphsid dfx:vc:28eaefa0-1811-4275-9d4c-130a3679473d

Data as of Sep 17, 2026 (this record's last observation) from Sworn filings; Announcements; Limited partners. Page built Sep 20, 2026, 11:13 AM UTC and rebuilt at most every 15 minutes.

Investor

Class

Fund

Partner

Role

Attribution

Stage 1 Managers LLC

Seed fund manager

n/a

unknown

Unknown

Sanofi

Candidate VC

n/a

unknown

Unknown

Omega Fund Management, LLC

Institutional VC

n/a

unknown

Unknown